Details
Ethacizin Indications
-ventricular and supraventricular arrhythmias,
paroxysmal atrial fibrillation and atrial flutter,
- ventricular and supraventricular tachycardia,
- including the syndrome of premature ventricular excitation.
Dosage & Administration
Inside, regardless of food intake, starting with 50 mg 2-3 times a day. In case of insufficient clinical effect dose increase (under ECG control binding) 4 to 50 mg twice a day (200 mg) or 100 mg three times a day (300 mg).
In achieving sustainable anti-arrhythmic effect of a supportive therapy in individually selected minimum effective doses. Some patients in order to achieve a stable antiarrhythmic action must be combined treatment etatsizin and β-adrenoceptor blockers.
Contradictions
- hypersensitivity to the drug or excipients;
- expressed conduction abnormalities (including sinoatrial block, AV-blockade II-III degree in the absence of an artificial pacemaker), violation of intraventricular conduction;
- marked hypertrophy of the left ventricle;
- the presence of myocardial infarction;
- cardiogenic shock;
- severe hypotension;
- chronic heart failure class II and III;
- expressed human liver and / or kidney problems;
- during pregnancy and breastfeeding;
- child age;
- simultaneous reception of MAO inhibitors;
- the simultaneous use of the IC antiarrhythmic drugs (moratsizin, propafenone, VFS) and Class IA (quinidine, procainamide, disopyramide, aymalin);
- etatsizin appointment of patients with all forms of cardiac arrhythmias in conjunction with the blockade of the system bundle of His - Purkinje fibers.